Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

141 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bleeding profile associated with 1-year use of the segesterone acetate/ethinyl estradiol contraceptive vaginal system: pooled analysis from Phase 3 trials.
Vieira CS, Fraser IS, Plagianos MG, Burke AE, Westhoff CL, Jensen J, Brache V, Bahamondes L, Merkatz R, Sitruk-Ware R, Blithe DL. Vieira CS, et al. Among authors: brache v. Contraception. 2019 Dec;100(6):438-444. doi: 10.1016/j.contraception.2019.07.145. Epub 2019 Aug 6. Contraception. 2019. PMID: 31398307 Free PMC article. Clinical Trial.
Serum Nestorone and ethinyl estradiol levels, and ovulation inhibition in women using three different dosage combinations of a Nestorone progestogen-ethinyl estradiol contraceptive vaginal ring on a bleeding-signaled regimen.
Fraser IS, Weisberg E, Brache V, Alvarez F, Massai R, Mishell DR Jr, Apter D, Gale J, Tsong YY, Sivin I. Fraser IS, et al. Among authors: brache v. Contraception. 2005 Jul;72(1):40-5. doi: 10.1016/j.contraception.2004.12.015. Contraception. 2005. PMID: 15964291 Clinical Trial.
Clinical performance and menstrual bleeding patterns with three dosage combinations of a Nestorone progestogen/ethinyl estradiol contraceptive vaginal ring used on a bleeding-signaled regimen.
Weisberg E, Brache V, Alvarez F, Massai R, Mishell DR Jr, Apter D, Gale J, Sivin I, Tsong YY, Fraser IS. Weisberg E, et al. Among authors: brache v. Contraception. 2005 Jul;72(1):46-52. doi: 10.1016/j.contraception.2004.12.014. Contraception. 2005. PMID: 15964292 Clinical Trial.
Pharmacokinetic study to compare the absorption and tolerability of two doses of levonorgestrel following single vaginal administration of levonorgestrel in Carraguard gel: a new formulation for "dual protection" contraception.
Sitruk-Ware R, Brache V, Maguire R, Croxatto H, Kumar N, Kumar S, Montero JC, Salvatierra AM, Phillips D, Faundes A. Sitruk-Ware R, et al. Among authors: brache v. Contraception. 2007 Jun;75(6):454-60. doi: 10.1016/j.contraception.2007.02.003. Epub 2007 Apr 18. Contraception. 2007. PMID: 17519152 Free PMC article. Clinical Trial.
Effect of a single vaginal administration of levonorgestrel in Carraguard gel on the ovulatory process: a potential candidate for "dual protection" emergency contraception.
Brache V, Croxatto H, Sitruk-Ware R, Maguire R, Montero JC, Kumar N, Salvatierra AM, Tejada AS, Cochón L, Forcelledo ML, Lahteenmaki P, Alvarez F, Faundes A. Brache V, et al. Contraception. 2007 Aug;76(2):111-6. doi: 10.1016/j.contraception.2007.04.005. Epub 2007 Jun 13. Contraception. 2007. PMID: 17656180 Free PMC article. Clinical Trial.
141 results